Novo Nordisk sold around 3.2 million combined prescriptions of Wegovy and Ozempic in the four weeks between Sept. 27 and Oct. 25, according to data from research firm IQVIA shared by a Wall Street analyst. Rival drugs from Eli Lilly in the GLP-1 class, Zepbound for weight loss, a...